Literature DB >> 8944819

Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels.

J L Hall1, G D Lopaschuk, A Barr, J Bringas, R D Pizzurro, W C Stanley.   

Abstract

OBJECTIVE: Malonyl CoA is an important regulator of fatty acid oxidation in the heart secondary to its ability to inhibit carnitine palmitoyltransferase 1 (CPT 1). Malonyl CoA is produced from acetyl CoA in a reaction catalyzed by acetyl CoA carboxylase (ACC). In this study we determined if alterations in malonyl CoA regulation of fatty acid metabolism are involved in the increase in energy transduction seen following an increase in cardiac work.
METHODS: Anesthetized, open-chest, domestic swine were subjected to a 30 min control period followed by a 30 min treatment period with either dobutamine (15 micrograms.kg-1. min-1 i.v.) (n = 6) or saline (n = 6).
RESULTS: Heart rate, left ventricular peak dp/dt, and MVO2, were significantly increased in the dobutamine group compared to the saline group during the treatment period. Free fatty acid and glucose uptake were increased 210 and 248%, respectively, in the dobutamine group during the treatment period. Malonyl CoA content was decreased by 55% (from 0.40 +/- 0.05 to 0.18 +/- 0.12 nmol/g wet wt; P < 0.05) with dobutamine treatment, but was not affected by saline treatment. ACC activity was not significantly different between groups (0.31 +/- 0.02 vs. 0.30 +/- 0.04 nmol. min-1. mg protein-1, respectively). The activity of AMP-dependent protein kinase (AMPK), which phosphorylates and inactivates ACC, was also not significantly different in the dobutamine hearts compared to the saline hearts (322 +/- 26 vs. 338 +/- 39 pmol. min-1. mg protein-1, respectively).
CONCLUSION: The increased cardiac work following dobutamine infusion is accompanied by a decrease in malonyl CoA levels and an increase in fatty acid uptake. However, the decrease in malonyl CoA cannot be explained by a decrease in ACC activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944819

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

Review 1.  Modulating fatty acid oxidation in heart failure.

Authors:  Vincenzo Lionetti; William C Stanley; Fabio A Recchia
Journal:  Cardiovasc Res       Date:  2011-02-02       Impact factor: 10.787

2.  Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze.

Authors:  Vijay Sharma; John H McNeill
Journal:  World J Cardiol       Date:  2011-09-26

3.  In vivo 13C spectroscopy in the rat brain using hyperpolarized [1-(13)C]pyruvate and [2-(13)C]pyruvate.

Authors:  Małgorzata Marjańska; Isabelle Iltis; Alexander A Shestov; Dinesh K Deelchand; Christopher Nelson; Kâmil Uğurbil; Pierre-Gilles Henry
Journal:  J Magn Reson       Date:  2010-07-16       Impact factor: 2.229

Review 4.  Energy metabolism in the normal and failing heart: potential for therapeutic interventions.

Authors:  William C Stanley; Margaret P Chandler
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

5.  High dose of aspirin moderates diabetes-induced changes of heart glycogen/glucose metabolism in rats.

Authors:  M Dervisevik; Suzana Dinevska-Kovkarovska; M Dimitrovska; N Cipanovska; B Miova
Journal:  J Physiol Sci       Date:  2014-09-03       Impact factor: 2.781

6.  Parallel activation of mitochondrial oxidative metabolism with increased cardiac energy expenditure is not dependent on fatty acid oxidation in pigs.

Authors:  Lufang Zhou; Marco E Cabrera; Hazel Huang; Celvie L Yuan; Duda K Monika; Naveen Sharma; Fang Bian; William C Stanley
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

Review 7.  AMPK alterations in cardiac physiology and pathology: enemy or ally?

Authors:  Jason R B Dyck; Gary D Lopaschuk
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

8.  The molecular basis of malonyl-CoA decarboxylase deficiency.

Authors:  D R FitzPatrick; A Hill; J L Tolmie; D R Thorburn; J Christodoulou
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

9.  Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation.

Authors:  Naveen Sharma; Isidore C Okere; Daniel Z Brunengraber; Tracy A McElfresh; Kristen L King; Joseph P Sterk; Hazel Huang; Margaret P Chandler; William C Stanley
Journal:  J Physiol       Date:  2004-11-18       Impact factor: 5.182

10.  Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.

Authors:  Patrick M Heck; Stephen P Hoole; Sadia N Khan; David P Dutka
Journal:  Cardiovasc Diabetol       Date:  2010-06-24       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.